Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis

Expert Review of Neurotherapeutics
Francesca BagnatoVasiliki N Ikonomidou

Abstract

Multiple sclerosis (MS) is an autoimmune disease of the CNS leading to clinical disability in 250,000-350,000 young adults in the USA and Europe. The disease affects both white matter (WM) and gray matter (GM) tissues of the brain and spinal cord. While WM disease is easily quantified using currently available magnetic resonance imaging (MRI) techniques, identification and quantification of GM disease present a daily challenge. Nonconventional brain and spinal cord MRI techniques, including magnetization transfer, MRI spectroscopy and diffusion tensor imaging, have improved our understanding of MS pathology in the deep GM. The sensitivity of high-resolution MRI obtained at a high magnetic field will improve the detection of spinal cord and brain cortical GM disease. The appropriate use of the above-mentioned techniques has the potential to more accurately explain the level of disability in MS patients.

References

Nov 1, 1992·Journal of Clinical Psychology·T Swirsky-SacchettiC F Gonzalez
Jul 1, 1992·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·V M HaughtonB O Khatri
Jan 1, 1992·The Journal of Neuropsychiatry and Clinical Neurosciences·S J HuberR B McGhee
Jul 1, 1990·Journal of Computer Assisted Tomography·C R JackD M Ilstrup
Sep 1, 1989·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·H B LarssonJ Olesen
Aug 1, 1988·Brain : a Journal of Neurology·D H MillerW I McDonald
Apr 1, 1986·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·D LacomisG Gross
Oct 1, 1986·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·D I HoultV J Sank
Apr 1, 1993·RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin·W SchimaH Imhof
Jan 1, 1995·Duodecim; lääketieteellinen aikakauskirja·M PaneliusJ Ruutiainen
Oct 1, 1996·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·M A van BuchemR I Grossman
Dec 1, 1996·Brain : a Journal of Neurology·N A LosseffA J Thompson
Feb 1, 1997·Journal of Clinical and Experimental Neuropsychology·R G KnightH P Godfrey
Mar 2, 1999·Brain : a Journal of Neurology·D KiddT Revesz
Mar 2, 1999·Brain : a Journal of Neurology·B SharrackG Dunn
Jun 4, 1999·Brain : a Journal of Neurology·G R CutterE Willoughby
Sep 1, 1999·Multiple Sclerosis : Clinical and Laboratory Research·J S FischerD Paty
Jan 25, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·M FilippiG Comi
May 16, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·V L StevensonA J Thompson
Sep 27, 2000·Journal of Manipulative and Physiological Therapeutics·C Pierre-JeromeS I Bekkelund
Sep 28, 2000·The New England Journal of Medicine·J H NoseworthyB G Weinshenker

❮ Previous
Next ❯

Citations

May 29, 2008·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ursula I TuorBoguslaw Tomanek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

International Review of Neurobiology
R Zivadinov, Jennifer L Cox
Handbook of Clinical Neurology
M FilippiM A Rocca
Therapeutic Advances in Neurological Disorders
Alex RoviraJuli Alonso
© 2022 Meta ULC. All rights reserved